Legal & General Group PLC Harmony Biosciences Holdings, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 112,953 shares of HRMY stock, worth $3.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,953

Previous 114,932 1.72%

Holding current value

$3.84 Million

Previous $3.63 Million 14.29%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$26.76 - $38.05 $52,958 - $75,300	-1,979 Reduced 1.72%	112,953 $3.11 Million
Q2 2025 Aug 12, 2025	BUY	$27.94 - $35.91 $129,725 - $166,730	4,643 Added 4.21%	114,932 $3.63 Million
Q1 2025 May 15, 2025	SELL	$32.18 - $40.46 $214,640 - $269,868	-6,670 Reduced 5.7%	110,289 $3.66 Million
Q4 2024 Feb 13, 2025	BUY	$31.86 - $41.49 $807,268 - $1.05 Million	25,338 Added 27.66%	116,959 $4.02 Million
Q3 2024 Feb 28, 2025	SELL	$30.0 - $39.95 $828,570 - $1.1 Million	-27,619 Reduced 23.61%	89,340 $3.57 Million

Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $85,650 - $114,057	-2,855 Reduced 3.02%	91,621 $3.66 Million
Q2 2024 May 29, 2025	SELL	$28.81 - $33.01 $49,322 - $56,513	-1,712 Reduced 1.82%	92,195 $2.78 Million
Q2 2024 Aug 14, 2024	BUY	$28.81 - $33.01 $16,392 - $18,782	569 Added 0.61%	94,476 $2.85 Million
Q1 2024 May 29, 2025	SELL	$29.93 - $35.06 $490,313 - $574,352	-16,382 Reduced 14.85%	93,907 $3.15 Million
Q1 2024 Jul 01, 2024	BUY	$29.93 - $35.06 $56,118 - $65,737	1,875 Added 2.04%	93,907 $3.15 Million
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $69,856 - $81,830	-2,334 Reduced 2.47%	92,032 $3.09 Million
Q4 2023 May 29, 2025	SELL	$19.2 - $33.78 $305,721 - $537,878	-15,923 Reduced 14.44%	94,366 $3.05 Million
Q4 2023 Feb 15, 2024	SELL	$19.2 - $33.78 $79,046 - $139,072	-4,117 Reduced 4.18%	94,366 $3.05 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $307,961 - $376,912	9,657 Added 10.87%	98,483 $3.23 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $250,710 - $307,428	8,220 Added 10.2%	88,826 $3.13 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $31,631 - $55,375	-1,027 Reduced 1.26%	80,606 $2.63 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $134,066 - $179,867	2,953 Added 3.75%	81,633 $4.5 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $767,679 - $1.01 Million	18,252 Added 30.2%	78,680 $3.48 Million
Q2 2022 Aug 22, 2022	BUY	$33.54 - $52.15 $272,378 - $423,510	8,121 Added 15.53%	60,428 $2.95 Million
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $10,671 - $16,463	-322 Reduced 0.61%	52,307 $2.55 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $1.57 Million - $2.03 Million	46,191 Added 717.47%	52,629 $2.25 Million
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $85,771 - $128,957	3,340 Added 107.81%	6,438 $246,000
Q2 2021 Aug 12, 2021	BUY	$25.96 - $33.44 $64,043 - $82,496	2,467 Added 390.97%	3,098 $88,000
Q4 2020 Feb 12, 2021	BUY	$31.74 - $51.34 $20,027 - $32,395	631 New	631 $23,000

Others Institutions Holding HRMY

# of Institutions

317

Shares Held

42.8M

Call Options Held

1.05M

Put Options Held

310K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.01B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Harmony Biosciences Holdings, Inc. Transaction History